Physician profile
Hyong Kim
NPI 1427236082
$248,259.18
in general payments reported to CMS, 2019-2025
8 companies · $36K in 2025
The $36K reported for 2025 was more than what 98% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $41K · 2021: $26K · 2022: $69K · 2023: $29K · 2024: $30K · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $47K · Education: $32K · Travel and Lodging: $11K · Food and Beverage: $6,047.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $46,708.29 |
| Education | $31,500.00 |
| Travel and Lodging | $11,132.24 |
| Food and Beverage | $6,047.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $165,861.88 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Medtronic, INC. | $55,099.89 | 2022-2025 | Signia, Ligasure, Interstim |
| Covidien Lp | $26,823.59 | 2019-2020 | |
| Tela Bio, INC. | $135.29 | 2024 | Ovitex 2s |
| Activ Surgical, INC. | $121.59 | 2023 | Activsight |
| Phathom Pharmaceuticals, INC. | $105.35 | 2024 | Voquezna |
| Virtual Incision Corporation | $57.00 | 2024 | Mira |
| Integra Lifesciences Corporation | $54.59 | 2025 | Integra, Omnigraft, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hyong Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.